A Dose Substitution of Anthracycline Intensity with Dose-Dense Rituximab in Children and Adolescents with Good-Risk Mature B-Cell Lymphoma

Authors

Stan Goldman
Qiuhu Shi, New York Medical CollegeFollow
Jessica Hochberg, New York Medical CollegeFollow
Liana Klejmont, New York Medical CollegeFollow
Yaya Chu, New York Medical CollegeFollow
Humayun Islam, New York Medical CollegeFollow
Perry Gerard, New York Medical CollegeFollow
Mitchell S. Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty

DOI

10.1038/s41375-021-01256-8

Journal Title

Leukemia

First Page

2994

Last Page

2997

Document Type

Article

Publication Date

10-2021

Department

Pediatrics

Second Department

Health Behavior and Community Health

Third Department

Radiology

Keywords

Adolescent, Adult, Anthracyclines, Antineoplastic Combined Chemotherapy Protocols, Child, Child, Preschool, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Lymphoma, B-Cell, Male, Prognosis, Rituximab, Survival Rate, Young Adult

Disciplines

Medicine and Health Sciences

Comments

Please see the work itself for a complete list of authors.

Recommended Citation

Goldman, S., Shi, Q., Hochberg, J., Klejmont, L., Chu, Y., Islam, H., Gerard, P., & Cairo, M. S. (2021). A Dose Substitution of Anthracycline Intensity with Dose-Dense Rituximab in Children and Adolescents with Good-Risk Mature B-Cell Lymphoma. Leukemia, 35 (10), 2994-2997. https://doi.org/10.1038/s41375-021-01256-8